Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.
about
Pharmacotherapy for chronic cognitive impairment in traumatic brain injuryMonoaminergic agonists for acute traumatic brain injuryA delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learningCatecholamines and cognition after traumatic brain injuryNon-Invasive Brain Stimulation for the Treatment of Symptoms Following Traumatic Brain Injury.The Controlled Cortical Impact Model: Applications, Considerations for Researchers, and Future DirectionsMethylphenidate on Cognitive Improvement in Patients with Traumatic Brain Injury: A Meta-AnalysisSafety of therapeutic methylphenidate in adults: a systematic review of the evidenceThe role of pharmacotherapy in the management of behaviour disorders in traumatic brain injury patients.Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisMethylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.Effect of growth hormone replacement therapy on cognition after traumatic brain injury.A double-blind, placebo-controlled intervention trial of 3 and 10 mg sublingual melatonin for post-concussion syndrome in youths (PLAYGAME): study protocol for a randomized controlled trialDifferential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain traumaWorking memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment -- a review.Acute treatment with the 5-HT(1A) receptor agonist 8-OH-DPAT and chronic environmental enrichment confer neurobehavioral benefit after experimental brain trauma.Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementiaPsychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury.Medical therapies for concussion.Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury.Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study.Use of methylphenidate in traumatic brain injury.Cognitive interventions post acquired brain injury.A review of pharmacological treatments used in experimental models of traumatic brain injury.Catecholaminergic based therapies for functional recovery after TBIAdministration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficitsMild traumatic brain injury: a neuropsychiatric approach to diagnosis, evaluation, and treatment.Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.Pharmacotherapy for treatment of attention deficits after non-progressive acquired brain injury. A systematic review.From the field of play to the field of combat: a review of the pharmacological management of concussion.5-hydroxytryptamine1A (5-HT1A) receptor agonists: A decade of empirical evidence supports their use as an efficacious therapeutic strategy for brain trauma.Long-term treatment with methylphenidate for fatigue after traumatic brain injury.Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study.Evaluation of dosage, safety and effects of methylphenidate on post-traumatic brain injury symptoms with a focus on mental fatigue and pain.Methylphenidate effect on hemispheric attentional imbalance in patients with traumatic brain injury: a psychophysical study.Reward context sensitivity impairment following severe TBI: an event-related potential investigation.Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.Methylphenidate reduces mental fatigue and improves processing speed in persons suffered a traumatic brain injury.Amantadine: a potential treatment for the minimally conscious state.The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study.
P2860
Q24187296-DF0642EA-1356-444F-B925-6C2A1442A914Q24244201-0E05D55D-48D8-40AC-8766-F0B007BBD209Q24651403-F08554ED-81FC-48E1-A277-D2699B9D3F17Q26743582-ADA88CC7-4B1F-421F-8451-80500FA071B6Q26784671-08BBA009-FCBD-4604-ACCC-F8DA02EACF17Q28067060-B4A6CE8A-7514-4D5C-90C1-8D863BFAD2F9Q28079841-525F251F-CAA9-4DAA-A7E5-D8B1BB5EE961Q28282264-BA8CAC25-B008-4CA8-96DC-1F4BEDCE16BBQ30826646-5356385D-D441-4EC9-A0D9-938733FBDB17Q33589580-6FD31367-ED2B-4370-86BC-DAB61DCAD29AQ34016523-B1098DAC-934C-402D-9330-28F686D02DEBQ34254777-DFFB6CFD-81E1-4EE6-8FD6-DCA1FFEA3E60Q34486287-05E64EEE-EB44-4D0F-B1C8-8354112D2E28Q34635707-3DFF15E9-782E-4E16-A2E3-7798F28DD1DCQ35637858-662A45C5-A712-46CD-8834-EF5CFAB4F932Q35746505-12BC9261-6FE2-43F9-9D31-FDE938CB9654Q35750668-D4070588-9885-48E5-B663-1757E1FB3D0BQ35894647-661450C9-810E-4562-B513-81721EDC9F37Q35986783-E8798518-E682-4AD2-ACA1-1E3EDCEBD79FQ35987622-D5180951-99EB-4F6B-A8AD-E95748E8A25AQ36013071-A37B3F18-D03B-4D7D-A6E9-B13F03815D8AQ36138151-A9B9B15F-B50E-47E1-80FF-3DA09DFDD111Q36761393-9AAB4F7B-9CB2-475D-87DD-08198E2F74ABQ36799413-7F2AFE7A-09E9-474F-B20C-F53D9AAC9B20Q36909436-7A14D9B1-83B9-405A-9357-FE34DDB3F728Q37018684-BA8D82B1-394C-457F-A9F3-2530497795FDQ37196141-45B5CCBC-05F8-405E-92FE-3548D6C0A95FQ37508249-19919ADD-6A35-4CC0-9F6A-19368B70A6BAQ37681935-A74BCE9F-DC65-4F3F-9744-8DC4A3CABB2CQ37979980-BB1FFDDB-E132-4BF5-82C9-4025CB74AEE7Q38650071-0A8FCF9D-27D1-4FB6-91C2-E74C05AC429EQ39908771-22A94E0F-10BA-45FE-B9FA-5AFAC316869AQ46964147-71CC66C4-744D-4796-A6F6-EE26DA827AECQ47814827-BB1AFA2A-5911-44FB-B940-ABDB855CFB95Q48157497-A49290E8-62A8-46B8-98A7-8F6682CDAC17Q48158651-FF65C396-C496-49B4-8680-61B587EEAB14Q48206338-7D94B62E-101D-4C1A-B537-03451675DF8EQ48270300-FF7CB149-0B71-4427-8A5A-62380527EA85Q48435469-D63E06EC-4D95-455F-A5D6-538E9471282CQ48651560-6D0888FC-EE99-48D1-BD5C-9E6742C9A696
P2860
Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Subacute methylphenidate treat ...... lind placebo-controlled study.
@en
Subacute methylphenidate treat ...... lind placebo-controlled study.
@nl
type
label
Subacute methylphenidate treat ...... lind placebo-controlled study.
@en
Subacute methylphenidate treat ...... lind placebo-controlled study.
@nl
prefLabel
Subacute methylphenidate treat ...... lind placebo-controlled study.
@en
Subacute methylphenidate treat ...... lind placebo-controlled study.
@nl
P2093
P1476
Subacute methylphenidate treat ...... lind placebo-controlled study.
@en
P2093
Castillo RM
Frankowski RF
Plenger PM
P304
P356
10.1016/S0003-9993(96)90291-9
P577
1996-06-01T00:00:00Z